Authentication and consumer engagement solutions creator YPB Group (ASX: YPB) has signed a three-year Master Service Agreement (MSA) with Addera, a Peru-based packaging company with clients in the country’s rice industry. Rice is a significant industry in Peru, accounting for 12% of agricultural production by value. Come 2026, the South American country is expected to
Read More
A 2023 McKinsey report shed light on research wherein one company with 5,000 customer service agents saw its issue resolution improve by 14% an hour, time spent reduce by 9%, and requests to speak to a manager decline by 25%—and it’s all thanks to generative AI. According to McKinsey, USD $4.4 trillion of value that
Read More
No more under-the-table deals, greasing palms, and paying more than you should, only to discover later that you got duped and were embarrassed to do anything about it. PropTech company Openn (ASX: OPN), through its private treaty platform Openn Offers, is attempting to enable fair market exchange between property buyers and sellers. In doing so,
Read More
A streamlined portfolio, new leadership, and layoffs—Aussie health, wellness and beauty products brand McPherson’s (ASX: MCP), the brand behind Manicare, Lady Jayne and Fusion Health, has begun damage control after its FY23 financials painted a worrying picture for shareholders. The Company’s new strategy will focus on its higher margin and higher growth categories where McPherson’s
Read More
Covid-19 reimagined the world’s approach to healthcare. While it put excessive strain on healthcare employees, it urged companies and governments to think outside the box and develop a more sustainable system for the post-pandemic world. Of course, that looked different for everyone. For countries like Estonia and the US, it entailed boosting telehealth services. For
Read More
Parkinson’s UK, in collaboration with Australian researchers, has taken a major step towards preventing the development of Parkinson’s disease with the first Australian patient in a Phase 2 clinical trial having been dosed with PXS-4708, a novel drug aimed at tackling Parkinson’s before its onset, along with other neurodegenerative disorders. The multi-national trial was initiated
Read More
After months of investing in new products and signing new contracts, sports performance analytics company Catapult (ASX: CAT) has scored big. For the first time since September 2021, the Company has generated positive free cash flow amounting to $2.2 million. And that is just scratching the surface. Catapult’s total revenue grew to $77 million, up
Read More
The week ahead may prove pivotal for the global bond markets. The US has roughly $33 trillion in Federal debt, at an average interest rate of roughly 3%, which generates around $1 trillion per year of interest cost. Based on current expectations, the Congressional Budget Office guesses that the government deficit from 2024 through 2033
Read More
As of early 2023, over three million Aussies aged 14 and above were found to either smoke or vape. With a greater number of teens and young Aussies taking up vaping, it has created a massive potential market for cannabis cultivators and manufacturers like ECS Botanics (ASX: ECS). ECS is launching a range of GMP-certified
Read More
Make passengers stand long enough in a queue, and you will eventually face their wrath. This is especially true at airports, where concerns about missing a flight take precedence (sometimes even over civility). As artificial intelligence (AI) grows, it can be helpful in analysing passenger data, helping you optimise how long it takes for them
Read More
